Preoperative MRI Intratumoral Heterogeneity Radiomics for Microvascular Invasion and Recurrence‐Free Survival in HCC
Liver International · 2026-08 · 46 (8)
DOI: 10.1111/liv.70818 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Liver International, online erschienen am 25.07.2026. Verfasst von Ruishan Liu und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Magnetic Resonance Imaging, Microvessels. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Ningxia Province, Science and Technology Project of Mianyang Municipal Health Commission.
Abstract (Originalsprache)
Background and Aims Microvascular invasion (MVI) is a major determinant of postoperative recurrence and poor prognosis in hepatocellular carcinoma (HCC), yet MVI cannot be reliably identified before surgery: pathologic evaluation is invasive, prone to sampling bias, and available only after resection. We aimed to develop and evaluate a preoperative radiomics biomarker for noninvasive MVI prediction and postoperative risk stratification of recurrence‐free survival.
Methods
In this retrospective multicenter study, 567 patients with HCC from four centers were included. Based on pretreatment MRI and clinical variables available before surgery, radiomics models characterising the global tumour region (GTR) and intratumoral heterogeneity (ITH) were developed and integrated into a Fusion model for preoperative prediction of MVI. Discrimination, calibration, and clinical utility were assessed using AUC, calibration curves, and decision‐curve analysis (DCA). Prognostic stratification was evaluated using C‐index, time‐dependent ROC analysis, and Kaplan–Meier analysis of recurrence‐free survival, and benchmarked against the Barcelona Clinic Liver Cancer (BCLC), China Liver Cancer (CNLC), and American Joint Committee on Cancer (AJCC) staging systems.
Results
The Fusion model showed higher discrimination than comparators in the validation and external test sets, achieving AUCs of 0.924 and 0.895, respectively. Ablation analyses showed incremental gains with the sequential addition of GTR features, ITH features, and clinical covariates. Fusion score‐based stratification identified high‐ and low‐risk groups with markedly divergent recurrence‐free survival. In the external test set, the prognostic model achieved a C‐index of 0.766 and time‐dependent AUCs of 0.825 at 2 years and 0.878 at 5 years, showing higher discrimination than BCLC, CNLC, and AJCC staging (all p < 0.001). Performance remained robust across HBV status, histologic differentiation, and BCLC stage.
Conclusions
A radiomics biomarker integrating global tumour phenotype, intratumoral heterogeneity, and preoperative clinical variables enables noninvasive preoperative MVI assessment and may complement morphology‐based staging for recurrence risk stratification in HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China.
- Zhejiang Key Laboratory of Multi-Omics Precision Diagnosis and Treatment of Liver Diseases, Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Radiology, General Hospital of Ningxia Medical University, Yinchuan, China.
- School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China.
- Department of Radiology, Huzhou Central Hospital, Affiliated to Huzhou University, Huzhou, China.
- Department of Radiology, Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Gang Ning, Fan Li, Lihua Zhuo
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Ningxia Province
- Science and Technology Project of Mianyang Municipal Health Commission
Zitieren
APA
Liu, R., Xie, Y., Yue, L., Jia, J., Wang, L., Liao, J., Li, H. W., Yao, H., Zhang, J., Wang, Y., Zhou, X., Shi, W., Ma, J., Chen, Q., Ma, X., Zhou, W., Yang, L., Ning, G., Zhou, Y., …, & Zhuo, L. (2026). Preoperative MRI Intratumoral Heterogeneity Radiomics for Microvascular Invasion and Recurrence‐Free Survival in HCC. Liver International, 46(8). https://doi.org/10.1111/liv.70818
Vancouver
Liu R, Xie Y, Yue L, Jia J, Wang L, Liao J, et al. Preoperative MRI Intratumoral Heterogeneity Radiomics for Microvascular Invasion and Recurrence‐Free Survival in HCC. Liver International. 2026;46(8). doi:10.1111/liv.70818
BibTeX
@article{Liu2026,
author = {Liu, Ruishan and Xie, Yangyang and Yue, Lv and Jia, Jing and Wang, Lu and Liao, Juan and Li, Hong-Wei and Yao, Hongchao and Zhang, Jie and Wang, Yanju and Zhou, Xingxiong and Shi, Wei and Ma, Jiangqin and Chen, Qian and Ma, Xueqin and Zhou, Wei and Yang, Lian and Ning, Gang and Zhou, Yong and Hu, Peixi and Li, Fan and Zhuo, Lihua},
title = {Preoperative MRI Intratumoral Heterogeneity Radiomics for Microvascular Invasion and Recurrence‐Free Survival in HCC},
journal = {Liver International},
year = {2026},
volume = {46},
number = {8},
doi = {10.1111/liv.70818}
}
EUVIMED